Skip to main content
    O

    Opus Genetics, Inc. (IRD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.04
    +0.06 (+1.51%)

    Market Cap: $384.68M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Opus Genetics, Inc. (IRD) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Opus Genetics (IRD) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Opus Genetics reported EPS of -$0.18, below the -$0.14 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    44%(16/36)
    Avg Surprise
    -35.67%

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.09
    Range-$0.19 - $0.20
    19 analysts
    Revenue Consensus
    $7.64M
    RangeN/A
    18 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.16
    Range-$0.19 - -$0.14
    3 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.17+1.0%
    60d ago-$0.15-6.5%
    30d ago-$0.15-6.5%
    7d ago-$0.15-6.5%
    Current-$0.16
    Revenue Consensus
    $1.41M
    RangeN/A
    5 analysts

    Next Report

    IRD has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 36 quarters below that had an estimate, IRD beat 16, missed 13 and matched 7. Revenue for the quarter ended Sep 30, 2026 was $1.14M, down 63.0% from $3.08M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.18-$0.14-$0.21 - -$0.09-28.57%MissN/A121 up, 0 downNov 10, 2026$1.14M
    Jun 30, 2026-$0.14-$0.15-$0.27 - -$0.09+6.67%BeatN/A130 up, 1 downAug 6, 2026$755000
    Mar 31, 2026-$0.75-$0.14-$0.18 - -$0.09-435.71%MissN/A60 up, 1 downMay 12, 2026$2.16M
    Dec 31, 2025-$0.21-$0.12N/A-78.27%MissN/A30 up, 0 downFeb 25, 2026$3.87M
    Sep 30, 2025-$0.25-$0.13-$0.13 - -$0.13-92.31%MissN/A10 up, 0 downNov 12, 2025$3.08M
    Jun 30, 2025-$0.12-$0.26N/A+53.85%BeatN/AN/AN/AAug 13, 2025$2.88M
    Mar 31, 2025-$0.32-$0.34N/A+5.88%BeatN/A10 up, 0 downMay 15, 2025$4.37M
    Dec 31, 2024-$1.27-$0.05-$0.34 - $0.55N/AN/AN/A30 up, 2 downMar 31, 2025$4.30M
    Sep 30, 2024-$0.29-$0.23N/A-26.09%Miss-216.0%N/AN/ANov 12, 2024$3.87M
    Jun 30, 2024-$0.30-$0.28N/A-7.14%MissN/AN/AN/AAug 13, 2024$1.11M
    Mar 31, 2024-$0.29-$0.14N/A-107.14%MissN/AN/AN/AMay 10, 2024$1.71M
    Dec 31, 2023-$0.21-$0.05N/A-320.00%Miss-112.4%N/AN/AMar 8, 2024$1.69M
    Sep 30, 2023$0.25-$0.23N/A+208.70%BeatN/AN/AN/ANov 13, 2023$11.94M
    Jun 30, 2023-$0.24-$0.24N/A0.00%In lineN/AN/AN/AAug 11, 2023$3.67M
    Mar 31, 2023-$0.28-$0.16N/A-75.00%MissN/AN/AN/AMay 15, 2023$1.75M
    Dec 31, 2022$1.69$1.00N/A+69.00%BeatN/AN/AN/AMar 31, 2023$39.85M
    Sep 30, 2022-$0.22-$0.29N/A+24.14%BeatN/AN/AN/ANov 4, 2022N/A
    Jun 30, 2022-$0.25-$0.33N/A+24.24%BeatN/AN/AN/AAug 12, 2022N/A
    Mar 31, 2022-$0.35-$0.35N/A0.00%In lineN/AN/AN/AMay 13, 2022N/A
    Dec 31, 2021-$0.35-$0.35N/A0.00%In lineN/AN/AN/AMar 31, 2022N/A
    Sep 30, 2021-$0.25-$0.36N/A+30.56%BeatN/AN/AN/ANov 12, 2021$489000
    Jun 30, 2021-$0.52-$0.41N/A-26.83%MissN/AN/AN/AAug 12, 2021$100000
    Mar 31, 2021-$0.47-$0.83N/A+43.37%BeatN/AN/AN/AMay 7, 2021N/A
    Dec 31, 2020-$4.70-$4.70N/A0.00%In lineN/AN/AN/AMar 31, 2021N/A
    Sep 30, 2020-$0.33-$0.33N/A0.00%In lineN/AN/AN/ANov 4, 2020N/A
    Jun 30, 2020-$2.50-$2.48N/A-0.81%MissN/AN/AN/AAug 10, 2020N/A
    Mar 31, 2020-$0.58-$0.60N/A+3.33%BeatN/AN/AN/AMay 18, 2020N/A
    Dec 31, 2019-$1.86-$2.00N/A+7.00%BeatN/AN/AN/AMar 16, 2020N/A
    Sep 30, 2019-$1.96-$1.96N/A0.00%In lineN/AN/AN/ADec 27, 2019N/A
    Jun 30, 2019-$2.44-$2.44N/A0.00%In lineN/AN/AN/AAug 7, 2019N/A
    Mar 31, 2019-$4.07-$0.93N/A-337.63%MissN/AN/AN/AMay 13, 2019N/A
    Dec 31, 2018-$4.32-$4.32N/A+0.04%BeatN/AN/AN/AMar 8, 2019N/A
    Sep 30, 2018-$8.16-$8.16N/A+0.04%BeatN/AN/AN/ANov 5, 2018N/A
    Jun 30, 2018-$5.76-$0.17N/AN/AN/A-400.0%N/AN/AAug 6, 2018N/A
    Mar 31, 2018-$3.36-$0.14N/AN/AN/AN/AN/AN/AMay 7, 2018N/A
    Dec 31, 2017-$5.76-$6.72N/A+14.32%BeatN/AN/AN/AMar 13, 2018N/A
    Sep 30, 2017-$1.92-$10.24N/A+81.25%BeatN/AN/AN/ANov 6, 2017N/A
    Jun 30, 2017$1.92-$10.08N/A+119.05%BeatN/AN/AN/AAug 7, 2017N/A
    Mar 31, 2017-$43.20-$8.00N/A-440.00%MissN/AN/AN/AMay 5, 2017N/A
    Dec 31, 2016-$1.06N/AN/AN/AN/AN/AN/AN/AFeb 27, 2017N/A
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.90, after -$2.15 the year before. It was -$21.23 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.90N/A
    Dec 31, 2024-$2.15N/A
    Dec 31, 2023-$0.48-155.2%
    Dec 31, 2022$0.87N/A
    Dec 31, 2021-$1.59N/A
    Dec 31, 2020-$8.11N/A
    Dec 31, 2019-$10.33N/A
    Dec 31, 2018-$21.60N/A
    Dec 31, 2017-$48.96N/A
    Dec 31, 2016-$21.23N/A

    Frequently Asked Questions About IRD

    When is Opus Genetics's next earnings date?

    Opus Genetics's next earnings report is expected for Mar 8, 2027.

    Did IRD beat earnings estimates last quarter?

    No. Opus Genetics reported EPS of -$0.18 for the quarter ended Sep 30, 2026, below the -$0.14 estimate by 28.57%.

    What EPS do analysts expect from IRD next quarter?

    The consensus EPS estimate for Opus Genetics for the quarter ending Dec 31, 2026 is -$0.09 from 19 analysts, with estimates from -$0.19 to $0.20.

    How often does IRD beat earnings estimates?

    Opus Genetics beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -74.32%.